Cerity Partners’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.91M Buy
179,341
+57,819
+48% +$2.05M 0.01% 1022
2025
Q4
$5.05M Sell
121,522
-18,249
-13% -$740K 0.01% 917
2025
Q3
$6.45M Buy
139,771
+43,509
+45% +$2.32M 0.01% 761
2025
Q2
$5.09M Buy
96,262
+28,451
+42% +$1.5M 0.01% 793
2025
Q1
$3.77M Buy
+67,811
New +$3.25M 0.01% 841
2024
Q4
Sell
-11,778
Closed -$604K 2462
2024
Q3
$604K Buy
11,778
+5,663
+93% +$379K ﹤0.01% 1669
2024
Q2
$387K Sell
6,115
-429
-7% -$25.7K ﹤0.01% 1673
2024
Q1
$433K Buy
+6,544
New +$531K ﹤0.01% 1665

Other funds holding CNXC

Cerity Partners's CNXC Position: Q1 2026 in Review

Cerity Partners increased its Concentrix (CNXC) stake by 48% in Q1 2026, buying an estimated $2.05M and bringing the position to 179,341 shares worth $4.91M. The position accounts for 0.01% of the portfolio, ranked #1022.

Cerity Partners first reported a position in CNXC in Q1 2024 and has held it in 8 quarters since. The position peaked at $6.45M in Q3 2025. 300 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Cerity Partners held 179,341 shares of Concentrix worth $4.91M as of Q1 2026.
  • Cerity Partners bought 57,819 Concentrix shares in Q1 2026, an estimated $2.05M.
  • Concentrix made up 0.01% of Cerity Partners's portfolio in Q1 2026, its #1022 holding.
  • Cerity Partners first reported a position in Concentrix in Q1 2024 and has held it in 8 quarters since.
  • Cerity Partners's Concentrix position peaked at $6.45M in Q3 2025.
  • 300 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.